Skin cancers

Questions raised about outcomes with Mohs surgery for melanoma

Patients with T1a-T2a invasive melanoma treated with Mohs micrographic surgery (MMS) at academic and higher case volume facilities have better overall survival than patients treated at nonacademic and low-volume facilities. A US study of over 4,000 patients treated at 462 centres reported 417 deaths during the ten-year study period. Survival at academic centres was 95.3% ...

Already a member?

Login to keep reading.

© 2021 the limbic